Long-Term Efficacy of Baricitinib in Alopecia Areata: 104-Week Results from BRAVE-AA1 and BRAVE-AA2 Authors: Maryanne Senna, Arash...

Safety Analysis of Baricitinib in Adult Patients with Severe Alopecia Areata from 2 Randomized Clinical Trials Over a Median of 1.6 Years...

Clinical Outcomes for Up-Titration with Baricitinib Therapy in Patients with Severe Alopecia Areata from BRAVE-AA1 and BRAVE-AA2 Authors:...

Baseline Distribution of Eyebrow and Eyelash Loss by Severity of Scalp Hair Loss in Phase 3 Trials of Baricitinib for Alopecia Areata...

Duration of Current Episode of Alopecia Areata (AA) Influences Prognosis During Treatment with Baricitinib in Patients with Severe AA...

Integrated Safety Analysis of Ritlecitinib for the Treatment of Alopecia Areata (AA) from the Phase 2 and Phase 3 ALLEGRO Clinical Trial...

Impact of Disease History on the Efficacy of Ritlecitinib in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3...